Showing results (131-140 of 369) with videos related to
Sort By:
Pageof 37
British Journal of Cancer|October 29, 2011
Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapiesV Grünwald, C Seidel, M Fenner, et al.Cancer Biotherapy|January 1, 1995
In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasisG Anastassiou, S Duensing, G Steinhoff, et al.Bone Marrow Transplantation|January 1, 1991
Successful stimulation of autologous bone marrow recovery by GM-CSF and IL-3 after an unrelated donor BMT for juvenile CML complicated by graft failureM Suttorp, N Schmitz, E Prange, et al.The Journal of Biological Chemistry|November 7, 1999
Functional analysis of a single chain chimeric alpha/beta-granulocyte-macrophage colony-stimulating factor receptor. Importance of a glutamate residue in the transmembrane regionS Kafert, S Luther, I Böll, et al.Transplantation|November 1, 1993
Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantationB Hertenstein, M Wiesneth, J Novotny, et al.Bone Marrow Transplantation|March 1, 1995
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMTB Hertenstein, W Hampl, D Bunjes, et al.Journal of Hematotherapy & Stem Cell Research|January 19, 2002
Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantationW H Krüger, R J Hornung, B Hertenstein, et al.Scandinavian Journal of Infectious Diseases|January 1, 1988
Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantationT Schmeiser, E Kurrle, R Arnold, et al.Bone Marrow Transplantation|April 1, 1995
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexateD Bunjes, B Hertenstein, M Wiesneth, et al.Leukemia|July 30, 2003
Synergistic cytotoxic effects in myeloid leukemia cells upon cotreatment with farnesyltransferase and geranylgeranyl transferase-I inhibitorsM A Morgan, J Wegner, E Aydilek, et al.Pageof 37